Beurs gesloten -
London S.E.
17:35:29 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
24,5
GBX
|
-3,92%
|
|
-18,33%
|
+58,06%
|
Fiscaal tijdperk: Juni |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
205
|
390,1
|
1.078
|
95,45
|
133,9
|
47,11
|
-
|
-
|
Bedrijfswaarde
1 |
195,7
|
377,3
|
1.013
|
66,46
|
121,2
|
47,11
|
47,11
|
47,11
|
K/w-verhouding
|
-
|
-41
x
|
-34,7
x
|
-1,64
x
|
-2,55
x
|
-
|
-
|
-
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
-
|
-
|
723
x
|
32,1
x
|
39,4
x
|
11,8
x
|
2,62
x
|
0,79
x
|
Bedrijfswaarde/omzet
|
-
|
-
|
723
x
|
32,1
x
|
39,4
x
|
11,8
x
|
2,62
x
|
0,79
x
|
Bedrijfswaarde/EBITDA
|
-37.874.147
x
|
-39.667.398
x
|
-35.317.377
x
|
-1.811.193
x
|
-3.200.093
x
|
-
|
-
|
-
|
Bedrijfswaarde/FCF
|
-
|
-37.508.576
x
|
-36.957.821
x
|
-2.053.446
x
|
-4.098.498
x
|
-
|
-
|
-
|
FCF Yield
|
-
|
-0%
|
-0%
|
-0%
|
-0%
|
-
|
-
|
-
|
Price to Book
|
7,28
x
|
9,83
x
|
11,5
x
|
2,21
x
|
-
|
-
|
-
|
-
|
Aantal aandelen (in duizenden)
|
53.816
|
59.416
|
72.197
|
74.760
|
93.781
|
154.368
|
-
|
-
|
Referentieprijs
2 |
3,809
|
6,565
|
14,93
|
1,277
|
1,428
|
0,3052
|
0,3052
|
0,3052
|
Datum van publicatie
|
3/09/19
|
27/10/20
|
21/10/21
|
31/10/22
|
28/09/23
|
-
|
-
|
-
|
Fiscaal tijdperk: Junio |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
-
|
-
|
1,491
|
2,97
|
3,403
|
4
|
18
|
60
|
EBITDA
|
-5,412
|
-9,834
|
-30,53
|
-52,7
|
-41,85
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-6,537
|
-11,08
|
-32,61
|
-57,37
|
-42,36
|
-32,2
|
-26,6
|
0,7
|
Operationele Marge
|
-
|
-
|
-2.187,19%
|
-1.931,72%
|
-1.244,64%
|
-805%
|
-147,78%
|
1,17%
|
Resultaat voor belastingen (EBT)
|
-
|
-10,61
|
-35,79
|
-49,63
|
-46,22
|
-
|
-
|
-
|
Nettowinst (verlies)
1 |
-
|
-9,25
|
-31,01
|
-56,65
|
-46,22
|
-35,5
|
-26,7
|
0,6
|
Nettomarge
|
-
|
-
|
-2.079,75%
|
-1.907,34%
|
-1.358,3%
|
-887,5%
|
-148,33%
|
1%
|
WPA
|
-
|
-0,1600
|
-0,4300
|
-0,7800
|
-0,5600
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-10,4
|
-29,17
|
-46,48
|
-32,67
|
-
|
-
|
-
|
FCF-marge
|
-
|
-
|
-1.956,54%
|
-1.565,02%
|
-960,15%
|
-
|
-
|
-
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
3/09/19
|
27/10/20
|
21/10/21
|
31/10/22
|
28/09/23
|
-
|
-
|
-
|
Fiscaal tijdperk: June |
2020 S1
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 Q3
|
---|
Omzet
1 |
-
|
0,482
|
0,845
|
0,812
|
0,831
|
0,969
|
1,192
|
0,724
|
0,518
|
0,459
|
0,709
|
1,1
|
1,6
|
2,5
|
3,8
|
4,7
|
EBITDA
|
-
|
-11,76
|
-13,74
|
-14,44
|
-15,8
|
-11,6
|
-9,527
|
-10,79
|
-9,948
|
-8,762
|
-8,227
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-
|
-11,88
|
-13,85
|
-14,57
|
-17,24
|
-11,73
|
-9,655
|
-10,92
|
-10,07
|
-8,889
|
-8,335
|
-8,4
|
-8,2
|
-7,7
|
-7,1
|
-6,5
|
Operationele Marge
|
-
|
-2.463,69%
|
-1.639,29%
|
-1.794,21%
|
-2.074,49%
|
-1.210,94%
|
-809,98%
|
-1.507,87%
|
-1.943,63%
|
-1.936,6%
|
-1.175,6%
|
-763,64%
|
-512,5%
|
-308%
|
-186,84%
|
-138,3%
|
Resultaat voor belastingen (EBT)
|
-
|
-10,11
|
-15,32
|
-14,7
|
-9,505
|
-
|
-10,44
|
-12,11
|
-11,72
|
-10,15
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettowinst (verlies)
1 |
-3,767
|
-10,11
|
-15,32
|
-14,7
|
-16,52
|
-11,95
|
-10,44
|
-12,11
|
-11,72
|
-10,15
|
-8,485
|
-8,5
|
-8,2
|
-7,7
|
-7,1
|
-6,5
|
Nettomarge
|
-
|
-2.096,68%
|
-1.813,25%
|
-1.809,73%
|
-1.988,57%
|
-1.233,54%
|
-876,17%
|
-1.672,1%
|
-2.262,16%
|
-2.212,2%
|
-1.196,76%
|
-772,73%
|
-512,5%
|
-308%
|
-186,84%
|
-138,3%
|
WPA
|
-0,000600
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
3/03/20
|
7/12/21
|
31/03/22
|
30/06/22
|
31/10/22
|
30/11/22
|
30/03/23
|
9/06/23
|
28/09/23
|
14/11/23
|
14/02/24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
9,29
|
12,8
|
64,8
|
29
|
12,7
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-10,4
|
-29,2
|
-46,5
|
-32,7
|
-
|
-
|
-
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-28,8%
|
-48%
|
-131%
|
-150%
|
-
|
-
|
-
|
ROA (netto-inkomsten/totale activa)
|
-
|
-26,3%
|
-43,8%
|
-
|
-
|
-
|
-
|
-
|
Totale activa
1 |
-
|
35,11
|
70,83
|
-
|
-
|
-
|
-
|
-
|
Nettoactief per aandeel
|
0,5200
|
0,6700
|
1,300
|
0,5800
|
-
|
-
|
-
|
-
|
Cashflow per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
0,34
|
0,77
|
-
|
-
|
-
|
-
|
-
|
Capex/omzet
|
-
|
-
|
51,84%
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
3/09/19
|
27/10/20
|
21/10/21
|
31/10/22
|
28/09/23
|
-
|
-
|
-
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +58,06% | 47,11 mln. | | -12,91% | 19,08 mld. | | -46,21% | 2,65 mld. | | +18,15% | 1,87 mld. | | -3,12% | 1,61 mld. | | +23,78% | 1,21 mld. | | -10,69% | 1,02 mld. | | -20,89% | 905 mln. | | -7,14% | 716 mln. | | -18,10% | 682 mln. |
Medisch diagnose- & testmateriaal
|